QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
th Floor Glendale |
||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company |
||||
Emerging growth company |
Page |
||||||
Item 1. |
||||||
Item 2. |
||||||
Item 3. |
||||||
Item 4. |
||||||
Item 1. |
||||||
Item 1A. |
||||||
Item 2. |
||||||
Item 3. |
||||||
Item 4. |
||||||
Item 5. |
||||||
Item 6. |
||||||
June 30, 2021 |
December 31, 2020 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Accounts receivable |
||||||||
Prepaid expenses and other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Goodwill |
||||||||
Intangible assets, net |
||||||||
Deferred income taxes |
||||||||
Restricted cash equivalent |
— | |||||||
Available-for-sale |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities, redeemable convertible preferred stock and stockholders’ deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses and other current liabilities |
||||||||
Deferred revenue |
||||||||
Current portion of long-term debt |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Long-term debt, net of current portion |
||||||||
Deferred revenue |
||||||||
Other liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies (Note 8) |
||||||||
Series A redeemable convertible preferred stock, $ |
||||||||
Stockholders’ deficit: |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total stockholders’ deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit |
$ | $ | ||||||
|
|
|
|
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Revenue |
$ | |
$ | |
$ | |
$ | |
||||||||
Cost of revenue |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
||||||||||||||||
Operating expenses: |
||||||||||||||||
Sales and marketing |
||||||||||||||||
Technology and development |
||||||||||||||||
General and administrative |
||||||||||||||||
Impairment of long-lived and other assets |
— | |||||||||||||||
Loss on sale of business |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
(Loss) income from operations |
( |
) | ( |
) | ||||||||||||
Interest expense, net |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Other income |
( |
) | ( |
) | ||||||||||||
Impairment of available-for-sale |
— | ( |
) | — | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Provision for (benefit from) from income taxes |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share attributable to common stockholders – basic and diluted: |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average shares used to compute net loss per share attributable to common stockholder – basic and diluted: |
||||||||||||||||
|
|
|
|
|
|
|
|
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive (loss) income, net of tax : |
||||||||||||||||
Change in foreign currency translation adjustments: |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Change in available-for-sale |
||||||||||||||||
Unrealized loss from available-for-sale debt securities |
( |
) | — | ( |
) | — | ||||||||||
Loss on impairment |
— | ( |
) | — | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net changes in available-for-sale |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Change in unrealized gain (loss) on cash flow hedges: |
||||||||||||||||
Unrealized gain (loss) on interest rate cap and swaps |
( |
) | ( |
) | ||||||||||||
Reclassification of prior hedge effectiveness and losses from interest rate cap to net loss |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net changes in cash flow hedges |
( |
) | ( |
) | ||||||||||||
Total other comprehensive income (loss) |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total comprehensive loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
|
|
|
|
|
|
|
|
Series A Redeemable Convertible Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total Stockholders’ Deficit |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||
Issuance of common stock upon exercise of stock options |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards |
— | — | — | — | — | — | — | |||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Shares surrendered for settlement of minimum statutory tax withholdings |
— | — | ( |
) | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||
Net interest and repayment of full recourse notes receivables |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Special dividends |
— | — | — | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at March 31, 2021 |
$ | |
$ | |
$ | |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||||||||||||
Issuance of common stock upon exercise of stock options |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards |
— | — | — | — | — | — | — | |||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Shares surrendered for settlement of minimum statutory tax withholdings |
— | — | ( |
) | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||
Special dividends |
— | — | — | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at June 30, 2021 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Redeemable Convertible Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total Stockholders’ Deficit |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||
Balance at December 31, 2019 |
$ | |
$ | |
$ | |
$ | ( |
$ | ( |
$ | ( |
) | |||||||||||||||||||
Issuance of common stock upon exercise of stock options |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards |
— | — | — | — | — | — | — | |||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Shares surrendered for settlement of minimum statutory tax withholdings |
— | — | ( |
) | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||
Net interest and repayment of full recourse notes receivables |
— | — | — | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||
Special dividends |
— | — | — | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||
Other comprehensive loss |
— | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at March 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||
Issuance of common stock upon exercise of stock options |
— | — | — | — | ||||||||||||||||||||||||||||
Issuance of common stock upon vesting of restricted stock awards |
— | — | — | — | — | — | — | |||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Shares surrendered for settlement of minimum statutory tax withholdings |
— | — | ( |
) | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||
Special dividends |
— | — | — | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||
Notes receivable from shareholder |
— | — | — | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||
Other comprehensive loss |
— | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at June 30, 2020 |
$ | |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30 |
||||||||
2021 |
2020 |
|||||||
Cash flows from operating activities |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
||||||||
Amortization of debt issuance costs |
||||||||
Amortization of prior hedge effectiveness |
||||||||
Stock-based compensation |
||||||||
Impairment of long-lived assets |
||||||||
Impairment of investments |
— | |||||||
Loss on sale of business |
— | |||||||
Deferred income taxes |
( |
) | ( |
) | ||||
Change in fair value of financial guarantee |
( |
) | ( |
) | ||||
Change in fair value of derivative instruments |
||||||||
Unrealized foreign exchange (gain) loss |
( |
) | ||||||
Other |
( |
) | ||||||
Changes in operating assets and liabilities, net of effects of disposal of business: |
||||||||
Accounts receivable |
( |
) | ( |
) | ||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||
Other assets |
( |
) | ( |
) | ||||
Accounts payable |
||||||||
Accrued expenses and other liabilities |
( |
) | ||||||
Income tax payable |
( |
) | ||||||
Deferred revenue |
||||||||
Net cash provided by operating activities |
||||||||
Cash flows from investing activities |
||||||||
Purchase of property and equipment |
( |
) | ( |
) | ||||
Sale of business, net of cash sold |
— | ( |
) | |||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
Cash flows from financing activities |
||||||||
Repayment of capital lease obligations |
( |
) | ( |
) | ||||
Repayment of 2018 Term Loan |
( |
) | ( |
) | ||||
Proceeds from 2018 Revolving Facility |
— | |||||||
Repayment of 2018 Revolving Facility |
— | ( |
) | |||||
Repayment of hybrid debt |
( |
) | ( |
) | ||||
Payment of initial public offering costs |
( |
) | — | |||||
Payment of contingent consideration |
( |
) | — | |||||
Payment of special dividends |
( |
) | ( |
) | ||||
Repurchases of common stock for tax withholding obligations |
( |
) | ( |
) | ||||
Proceeds from exercise of stock options, net of cash paid for employee tax withholding |
||||||||
Net cash used in financing activities |
( |
) | ( |
) | ||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalent |
( |
) | ||||||
Net increase in cash, cash equivalents and restricted cash equivalent |
||||||||
Cash, cash equivalents and restricted cash equivalent, at beginning of the period |
||||||||
Cash, cash equivalents and restricted cash equivalent, at end of the period |
$ | $ | ||||||
Reconciliation of cash, cash equivalents, and restricted cash equivalent reported in the consolidated balance sheets |
||||||||
Cash and cash equivalents |
$ | |
$ | |||||
Restricted cash equivalent |
— | |||||||
Total cash, cash equivalents, and restricted cash equivalent shown in the condensed consolidated statements of cash flows |
$ | $ | |
|||||
Non-cash investing and financing activities |
||||||||
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities |
$ | $ | ||||||
Change in fair value of hedged interest rate swaps and interest rate cap |
( |
) | ||||||
Transfer of interest rate swaps derivative liability to hybrid debt |
— | |||||||
Deferred offering costs included in accounts payable and accrued expenses and other current liabilities |
— | |||||||
Deferred financing costs included in accounts payable and accrued expenses and other current liabilities |
— |
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Transaction |
$ | $ | $ | |
$ | |||||||||||
Subscription |
||||||||||||||||
Partner |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
$ | |
$ | |
$ | $ | |
|||||||||
|
|
|
|
|
|
|
|
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Beginning balance |
$ | $ | |
$ | $ | |||||||||||
Add: amounts recognized as a reduction of revenue |
||||||||||||||||
Add: bad debt expense recognized in general and administrative expense |
||||||||||||||||
Less: write-offs, net of recoveries |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Ending balance |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
June 30, 2021 |
December 31, 2020 |
|||||||
Prepaid expenses |
$ | |
$ | |
||||
Deferred cost of revenue |
||||||||
Other current assets |
||||||||
|
|
|
|
|||||
Total prepaid expenses and other current assets |
$ | |
$ | |
||||
|
|
|
|
June 30, 2021 |
December 31, 2020 |
|||||||
Accrued payroll and related expenses |
$ | |
$ | |
||||
Accrued vendor payables |
||||||||
Derivative liabilities and hybrid debt |
||||||||
Sales allowances |
||||||||
Accrued sales, use and business taxes |
||||||||
Accrued advertising |
— | |||||||
Other |
||||||||
|
|
|
|
|||||
Total accrued expenses and other current liabilities |
$ | $ | ||||||
|
|
|
|
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Cost of revenue |
$ | |
$ | |
$ | |
$ | |
||||||||
Sales and marketing |
||||||||||||||||
Technology and development |
||||||||||||||||
General and administrative |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total depreciation and amortization expense |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
June 30, 2021 |
December 31, 2020 |
|||||||
Current portion of 2018 Term Loan |
$ | $ | ||||||
Current portion of discount and unamortized debt issuance costs |
( |
) | ( |
) | ||||
Total current portion of long-term debt |
||||||||
Noncurrent portion of 2018 Term Loan |
||||||||
Noncurrent portion of discount and unamortized debt issuance costs |
( |
) | ( |
) | ||||
Total long-term debt, net of current portion |
$ | |
$ | |
||||
2021 (remaining six months) |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
Total long-term debt, net of current portion |
||||
Less: current portion of 2018 Term Loan |
( |
) | ||
Outstanding principal of 2018 Term Loan, net of current portion |
$ | |
||
June 30, 2021 |
December 31, 2020 |
|||||||
Interest rate swap derivative liability, current portion |
$ | |
$ | |
||||
Interest rate swaps |
||||||||
Financial guarantee |
— | |||||||
|
|
|
|
|||||
Total derivative liability, net of current portion |
$ | $ | ||||||
|
|
|
|
|||||
Hybrid debt, current portion |
$ | $ | ||||||
|
|
|
|
|||||
Hybrid debt, net of current portion |
$ | $ | ||||||
|
|
|
|
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Net payments upon settlement of interest rate swaps |
$ | $ | $ | |
$ | |||||||||||
Amortization of prior hedge effectiveness |
||||||||||||||||
Amortization of interest rate cap premium |
— | |||||||||||||||
Interest expense on hybrid debt |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total, recorded in interest expense, net |
$ | |
$ | |
$ | $ | |
|||||||||
|
|
|
|
|
|
|
|
Operating Leases |
||||
2021 (remaining six months) |
$ | |
||
2022 |
||||
|
|
|||
Total minimum lease payments |
$ | |||
|
|
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Cost of revenue |
$ | $ | $ | $ | ||||||||||||
Sales and marketing |
||||||||||||||||
Technology and development |
||||||||||||||||
General and administrative |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total stock-based compensation expense |
||||||||||||||||
Amount capitalized to internal-use software |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total stock-based compensation |
$ | |
$ | |
$ | |
$ | |
||||||||
|
|
|
|
|
|
|
|
Number of Options |
Weighted- Average Exercise Price |
Weighted- Average Remaining Contractual Life (in Years) |
Aggregate Intrinsic Value |
|||||||||||||
Outstanding at December 31, 2020 |
$ | |||||||||||||||
Granted |
||||||||||||||||
Exercised |
( |
) | ||||||||||||||
Cancelled/forfeited |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding at June 30, 2021 |
$ | |
$ | |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Vested and expected to vest at June 30, 2021 |
$ | $ | ||||||||||||||
Exercisable at June 30, 2021 |
$ | $ |
Three Months Ended June 30 |
Six Months Ended June 30 |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Expected life (years) |
— | |||||||||||||||
Risk-free interest rate |
% | — | % | % | ||||||||||||
Expected volatility |
% | — | % | % | ||||||||||||
Expected dividend yield |
% | — | % | % |
Number of Options |
Weighted- Average Grant- Date Fair Value |
|||||||
Unvested at December 31, 2020 |
$ | |||||||
Granted |
||||||||
Cancelled/forfeited |
( |
) | ||||||
Vested |
( |
) | ||||||
|
|
|
|
|||||
Unvested at June 30, 2021 |
$ | |
||||||
|
|
|
|